- Research works
- 95 ▲ 45% vs 2013–17
- Citations
- 1.1k 11.6 per fractional work
- Top-10% rate
- 13.8% record average 16.5%
- Open access
- 65% world 28%
Not ranked overall: Sanofi (Japan) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 7.5×. Every wedge is a field page.
- Immunology and Microbiology 7.5×
- Pharmacology, Toxicology and Pharmaceutics 7.3×
- Medicine 4.1×
- Mathematics 2.5×
- Biochemistry, Genetics and Molecular Biology 0.9×
- Economics, Econometrics and Finance 0.3×
- Psychology 0.2×
- Agricultural and Biological Sciences 0.2×
- Computer Science 0.1×
- Environmental Science 0.1×
- Social Sciences 0.0×
- Engineering 0.0×
Who are the top researchers at Sanofi (Japan)?
Ranked on the composite score, Kazuhiko Arima lead among researchers whose main affiliation is Sanofi (Japan).
- 1 Kazuhiko Arima Japan · #397,543 worldwide 101 citations · 20 works
Which keywords describe research at Sanofi (Japan)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Quality of Life, Asthma, Immune Dysregulation, Filaggrin, Skin Microbiome, Treatment and Glycemic Control.
- Prognostic Factors
- Urticaria
- Pathogenesis
- Cardiovascular Disease
- Heart Failure
- Allergic Diseases
- Diabetes
- Respiratory Syncytial Virus
- Pollen Allergy
- Autoantibodies
- Management
- Genetics
- Glycemic Control
- Inflammation
- Skin Microbiome
- Immune Dysregulation
- Quality of Life
- Epidemiology
- Asthma
- Filaggrin
- Treatment
- Diagnosis
- Climate Change
- Insulin Therapy
- Allergen-specific Immunotherapy
- Clinical Trials
- Human Metapneumovirus
- Adverse Drug Reactions
- Genetic Mutations
- Eosinophils
- Biomarkers
- Chronic Spontaneous Urticaria
- Rituximab
- Clinical Guidelines
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 34 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 34 words, with their numbers
- Epidemiology8▲ 6.5×17 topics
- Quality of Life3▲ 7.9×5 topics
- Asthma3▲ 92×2 topics
- Immune Dysregulation3▲ 110×2 topics
- Filaggrin2▲ 143×1 topic
- Skin Microbiome2▲ 143×1 topic
- Treatment2▲ 5.9×4 topics
- Inflammation2▲ 3.3×7 topics
- Diagnosis2▲ 6.4×4 topics
- Glycemic Control2▲ 37×4 topics
- Climate Change2▲ 1.99×2 topics
- Genetics2▲ 7.8×2 topics
- Insulin Therapy2▲ 43×3 topics
- Management2▲ 6.8×3 topics
- Allergen-specific Immunotherapy2▲ 159×1 topic
- Autoantibodies2▲ 22×3 topics
- Clinical Trials2▲ 7.3×5 topics
- Pollen Allergy2▲ 159×1 topic
- Human Metapneumovirus1▲ 100×1 topic
- Respiratory Syncytial Virus1▲ 100×1 topic
- Adverse Drug Reactions1▲ 80×3 topics
- Diabetes1▲ 9.1×4 topics
- Genetic Mutations1▲ 10×5 topics
- Allergic Diseases1▲ 68×1 topic
- Eosinophils1▲ 68×1 topic
- Heart Failure1▲ 9.2×3 topics
- Biomarkers1▲ 5.3×2 topics
- Cardiovascular Disease1▲ 3.4×2 topics
- Chronic Spontaneous Urticaria1▲ 167×1 topic
- Pathogenesis1▲ 7.1×4 topics
- Rituximab1▲ 25×3 topics
- Urticaria1▲ 167×1 topic
- Clinical Guidelines1▲ 12×2 topics
- Prognostic Factors1▲ 7.8×3 topics
Which research topics does Sanofi (Japan) publish most on?
By volume in 2022–2025: Dermatology and Skin Diseases, Allergic Rhinitis and Sensitization, Respiratory viral infections research and Asthma and respiratory diseases.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Dermatology and Skin Diseases Dermatology 2 works
- 2 Allergic Rhinitis and Sensitization Immunology and Allergy 2 works
- 3 Respiratory viral infections research Epidemiology 1 works
- 4 Asthma and respiratory diseases Physiology 1 works
- 5 Urticaria and Related Conditions Rheumatology 1 works
- 6 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 1 works
- 7 Statistical Methods in Clinical Trials Statistics and Probability 1 works
- 8 Influenza Virus Research Studies Epidemiology 1 works
- 9 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 1 works
- 10 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Sanofi (Japan)'s research output changed?
Output in 2018–2022 was 45% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Tokyo
- The University of Tokyo
- Tokyo Institute of Technology
- Keio University
- Waseda University
- Tokyo University of Science
- Nihon University
- Hitachi (Japan)
- NTT (Japan)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.